{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:44:56Z","timestamp":1771332296566,"version":"3.50.1"},"reference-count":39,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Zambon Pharmaceuticals","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Fam Med Com Health"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The objective of our study was to evaluate the impact of a multifaceted stewardship intervention on adherence to the evidence-based practice guidelines on treatment of uncomplicated cystitis in primary care. We hypothesised that our intervention would increase guideline adherence in terms of antibiotic choice and duration of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A preintervention and postintervention comparison with a contemporaneous control group was performed. During the first two study periods, we obtained baseline data and performed interviews exploring provider prescribing decisions for cystitis at both clinics. During the third period in the intervention clinic only, the intervention included a didactic lecture, a decision algorithm and audit and feedback. We used a difference-in-differences analysis to determine the effects of our intervention on the outcome and guideline adherence to antibiotic choice and duration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Two family medicine clinics (one intervention and one control) were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>All female patients with uncomplicated cystitis attending the study clinics between 2016 and 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our sample included 932 visits representing 812 unique patients with uncomplicated cystitis. The proportion of guideline-adherent antibiotic regimens increased during the intervention period (from 33.2% (95% CI 26.9 to 39.9) to 66.9% (95% CI 58.4 to 74.6) in the intervention site and from 5.3% (95% CI 2.3 to 10.1) to 17.0% (95% CI 9.9 to 26.6) in the control site). The increase in guideline adherence was greater in the intervention site compared with the control site with a difference-in-differences of 22\u2009percentage points, p=0.001.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A multifaceted intervention increased guideline adherence for antibiotic choice and duration in greater magnitude than similar trends at the control site. Future research is needed to facilitate scale-up and sustainability of case-based audit and feedback interventions in primary care.<\/jats:p><\/jats:sec>","DOI":"10.1136\/fmch-2020-000834","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T15:53:55Z","timestamp":1625846035000},"page":"e000834","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Case-based audit and feedback around a decision aid improved antibiotic choice and duration for uncomplicated cystitis in primary care clinics"],"prefix":"10.1136","volume":"9","author":[{"given":"Larissa","family":"Grigoryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Zoorob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Germanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Sidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Horsfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Trautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"2021070908501902000_9.3.e000834.1","unstructured":"Centers for Disease Control and Prevention . Antibiotic resistance threats in the United States. U.S. Department of Health and Human Services., 2019. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf"},{"key":"2021070908501902000_9.3.e000834.2","unstructured":"The Joint Commission . Antimicrobial stewardship in ambulatory health care. Available: https:\/\/www.jointcommission.org\/standards\/r3-report\/r3-report-issue-23-antimicrobial-stewardship-in-ambulatory-health-care\/"},{"key":"2021070908501902000_9.3.e000834.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0275"},{"key":"2021070908501902000_9.3.e000834.4","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2014.41"},{"key":"2021070908501902000_9.3.e000834.5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/pds.5018","article-title":"Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning","volume":"29","author":"Bratsman","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2021070908501902000_9.3.e000834.6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw159"},{"key":"2021070908501902000_9.3.e000834.7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy198"},{"key":"2021070908501902000_9.3.e000834.8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/jgs.15518","article-title":"Outpatient antibiotic prescribing for older adults in the United States: 2011 to 2014","volume":"66","author":"Kabbani","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2021070908501902000_9.3.e000834.9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv159"},{"key":"2021070908501902000_9.3.e000834.10","first-page":"242","article-title":"Improvement in adherence to antibiotic duration of therapy recommendations for uncomplicated cystitis: a quasi-experimental study","volume":"37","author":"Giancola","year":"2020","journal-title":"Fam Pract"},{"key":"2021070908501902000_9.3.e000834.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1668-9"},{"key":"2021070908501902000_9.3.e000834.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-12-108"},{"key":"2021070908501902000_9.3.e000834.13","doi-asserted-by":"publisher","DOI":"10.1002\/pds.862"},{"key":"2021070908501902000_9.3.e000834.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322678111"},{"key":"2021070908501902000_9.3.e000834.15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/1060028019865224","article-title":"Evaluation of FDA Boxed warning on prescribing patterns of fluoroquinolones for uncomplicated urinary tract infections","volume":"53","author":"Cowart","year":"2019","journal-title":"Ann Pharmacother"},{"key":"2021070908501902000_9.3.e000834.16","unstructured":"U.S. Food and Drug Administration . FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together, 2016. Available: https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM500591.pdf"},{"key":"2021070908501902000_9.3.e000834.17","unstructured":"U.S. Food and Drug Administration . FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. Available: https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm612995.htm"},{"key":"2021070908501902000_9.3.e000834.18","unstructured":"U.S. Food and Drug Administration . FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients, 2018. Available: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm628753.htm"},{"key":"2021070908501902000_9.3.e000834.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.04.014"},{"key":"2021070908501902000_9.3.e000834.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"2021070908501902000_9.3.e000834.21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2015.1878","article-title":"Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria","volume":"175","author":"Trautner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2021070908501902000_9.3.e000834.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087899"},{"key":"2021070908501902000_9.3.e000834.23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajic.2014.06.020","article-title":"Lessons from audit and feedback of hospitalized patients with bacteriuria","volume":"42","author":"Leis","year":"2014","journal-title":"Am J Infect Control"},{"key":"2021070908501902000_9.3.e000834.24","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800278","article-title":"Antimicrobial prescribing and infections in long-term care facilities (LTCF): a multilevel analysis of the HALT 2016 study, Ireland, 2017","volume":"23","author":"Tandan","year":"2018","journal-title":"Euro Surveill"},{"key":"2021070908501902000_9.3.e000834.25","first-page":"771","article-title":"Diagnosis and treatment of acute uncomplicated cystitis","volume":"84","author":"Colgan","year":"2011","journal-title":"Am Fam Physician"},{"key":"2021070908501902000_9.3.e000834.26","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9090536","article-title":"Validating use of electronic health data to identify patients with urinary tract infections in outpatient settings","volume":"9","author":"Germanos","year":"2020","journal-title":"Antibiotics"},{"key":"2021070908501902000_9.3.e000834.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.12842"},{"key":"2021070908501902000_9.3.e000834.28","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics8020084","article-title":"Qualitative analysis of primary care provider prescribing decisions for urinary tract infections","volume":"8","author":"Grigoryan","year":"2019","journal-title":"Antibiotics"},{"key":"2021070908501902000_9.3.e000834.29","doi-asserted-by":"publisher","DOI":"10.1037\/\/0033-2909.119.2.254"},{"key":"2021070908501902000_9.3.e000834.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004796"},{"key":"2021070908501902000_9.3.e000834.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.9.867"},{"key":"2021070908501902000_9.3.e000834.32","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.093328"},{"key":"2021070908501902000_9.3.e000834.33","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy101","article-title":"Leveraging antimicrobial stewardship in the emergency department to improve the quality of urinary tract infection management and outcomes","volume":"5","author":"Jorgensen","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2021070908501902000_9.3.e000834.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4151"},{"key":"2021070908501902000_9.3.e000834.35","unstructured":"Centers for Disease Control and Prevention . Measuring outpatient antibiotic prescribing. Key U.S. Statistics. Available: https:\/\/www.cdc.gov\/antibiotic-use\/community\/programs-measurement\/measuring-antibiotic-prescribing.html#statistics"},{"key":"2021070908501902000_9.3.e000834.36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.japh.2019.03.006","article-title":"Development and implementation of a clinical decision support tool for treatment of uncomplicated urinary tract infections in a family medicine resident clinic","volume":"59","author":"Eudaley","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"2021070908501902000_9.3.e000834.37","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/cid\/ciz482","article-title":"The Urine-culturing cascade: variation in nursing home urine culturing and association with antibiotic use and Clostridiodes difficile infection","volume":"70","author":"Brown","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021070908501902000_9.3.e000834.38","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1093\/jac\/dkz392","article-title":"The effectiveness of repeating a social norm feedback intervention to high prescribers of antibiotics in general practice: a national regression discontinuity design","volume":"74","author":"Ratajczak","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021070908501902000_9.3.e000834.39","unstructured":"Yoon J . Natural experiments and Difference-in-Differences. VA Health Services Research & Development, 2019. https:\/\/www.hsrd.research.va.gov\/for_researchers\/cyber_seminars\/archives\/3553-notes.pdf"}],"container-title":["Family Medicine and Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fmch-2020-000834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T15:54:15Z","timestamp":1625846055000},"score":1,"resource":{"primary":{"URL":"https:\/\/fmch.bmj.com\/lookup\/doi\/10.1136\/fmch-2020-000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/fmch-2020-000834"],"URL":"https:\/\/doi.org\/10.1136\/fmch-2020-000834","relation":{},"ISSN":["2305-6983","2009-8774"],"issn-type":[{"value":"2305-6983","type":"print"},{"value":"2009-8774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}